Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
Transplantation and Cellular Therapy|March 30, 2021
Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow TransplantationNina Worel, Bronwen E Shaw, Mahmoud Aljurf, et al.
Leukemia & Lymphoma|May 22, 2014
An imatinib-only window followed by imatinib and chemotherapy for Philadelphia chromosome-positive acute leukemia: long-term results of the CMLALL1 trialJason D Lickliter, Kerry Taylor, Jeff Szer, et al.
The Lancet. Haematology|February 2, 2019
Eltrombopag treatment during induction chemotherapy for acute myeloid leukaemia: a randomised, double-blind, phase 2 studyNoelle Frey, Jun Ho Jang, Jeff Szer, et al.
Arthritis and Rheumatism|October 2, 2002
A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritisJohn Moore, Peter Brooks, Sam Milliken, et al.
The Journal of Biological Chemistry|January 22, 2013
Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cellsSusan L Heatley, Gabriella Pietra, Jie Lin, et al.
Revista Brasileira De Hematologia E Hemoterapia|October 11, 2012
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantationNavneet Singh Majhail, James Douglas Rizzo, Stephanie Joi Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 20, 2011
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantationNavneet S Majhail, J Douglas Rizzo, Stephanie J Lee, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 2014
[Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation]Navneet S Majhail, J Douglas Rizzo, Stephanie J Lee, et al.
Blood|March 25, 2006
Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trialMats Brune, Sylvie Castaigne, John Catalano, et al.
The New England Journal of Medicine|September 10, 2015
Eculizumab in Pregnant Patients with Paroxysmal Nocturnal HemoglobinuriaRichard J Kelly, Britta Höchsmann, Jeff Szer, et al.
Pageof 15